Linde PLC — Director's Dealing 2025

Mar 11, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LINDE PLC (LIN)
CIK: 0001707925
Period of Report: 2025-03-07

Reporting Person: Lamba Sanjiv (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-10	Ordinary Shares	M	6335	—	Acquired	74610.95	Direct
2025-03-10	Ordinary Shares	F	2786.767	$468.77	Disposed	71824.183	Direct
2025-03-10	Ordinary Shares	M	19000	—	Acquired	90824.183	Direct
2025-03-10	Ordinary Shares	F	8804.601	$468.77	Disposed	82019.582	Direct
2025-03-10	Ordinary Shares	M	11656	—	Acquired	93675.582	Direct
2025-03-10	Ordinary Shares	F	5401.391	$468.77	Disposed	88274.191	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-10	Performance Share Units (ROC)	$0	A	19000	Acquired		Ordinary Shares (19000)	Direct
2025-03-10	Performance Share Units (ROC)	$0	M	19000	Disposed		Ordinary Shares (19000)	Direct
2025-03-10	Performance Share Units (RTSR)	$0	A	11656	Acquired		Ordinary Shares (11656)	Direct
2025-03-10	Performance Share Units (RTSR)	$0	M	11656	Disposed		Ordinary Shares (11656)	Direct
2025-03-10	Restricted Stock Units	$	M	6335	Disposed		Ordinary Shares (6335)	Direct
2025-03-07	Restricted Stock Units	$0	A	6364	Acquired		Ordinary Shares (6364)	Direct
2025-03-07	Stock Options (right to buy)	$468.77	A	44696	Acquired	2035-03-07	Ordinary Shares (44696)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Units	$		Ordinary Shares (6405)	6405	Direct
Restricted Stock Units	$		Ordinary Shares (7015)	7015	Direct
Stock Options (right to buy)	$465.29	2034-03-07	Ordinary Shares (41530)	41530	Direct
Stock Options (right to buy)	$354.14	2033-03-07	Ordinary Shares (46365)	46365	Direct
Stock Options (right to buy)	$270.99	2032-03-07	Ordinary Shares (54920)	54920	Direct
Stock Options (right to buy)	$253.68	2031-03-08	Ordinary Shares (40995)	40995	Direct
Stock Options (right to buy)	$173.13	2030-03-09	Ordinary Shares (37565)	37565	Direct
Stock Options (right to buy)	$176.63	2029-03-20	Ordinary Shares (15470)	15470	Direct
Deferred Stock Units	$0		Ordinary Shares (406.322)	406.322	Direct

Footnotes

F1: Ordinary shares acquired pursuant to the payout of a restricted stock unit grant made on March 7, 2022.

F2: Ordinary shares withheld from the payout to cover tax withholdings.

F3: Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2022.

F4: The PSU paid out on March 10, 2025 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2022-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022.

F5: The PSU paid out on March 10, 2025 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2022-2025 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022.

F6: Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.

F7: Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis

F8: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.

F9: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.

F10: Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.

F11: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.

F12: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.

F13: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.

F14: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.

F15: This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.

F16: Stock options have been granted pursuant to the Business Combination Agreement among Praxair, Inc., Linde AG, Linde plc and certain of their affiliates, dated June 1, 2017, as amended (the "BCA"). The stock options replace certain previously granted equity awards granted by Linde AG that were terminated in connection with the closing of the Business Combination of Praxair, Inc. and Linde AG that occurred on October 31, 2018. A more detailed explanation of these stock option replacement awards is discussed in the Linde plc Registration Statement on Form S-4 (Amendment No. 4) filed with the SEC on August 11, 2017 under the section titled "The Business Combination - Interests of Directors, Board Members and Executive Officers in the Business Combination - Linde AG - Treatment of Equity Awards" on pages 183-187.

F17: This option vests over three years in three consecutive equal annual installments beginning March 20, 2020.

F18: Deferred Stock Units acquired under the Linde Compensation Deferral Plan that will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Deferral Plan.